Abstract 1884: Molecular determinants of sensitivity and resistance to the pan-RAS(ON) inhibitor daraxonrasib(RMC-6236) across KRAS-mutant patient-derived models.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Champions Oncology (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148869793
Cites:
Cited by:
Related to:
